title: WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships.
abstract: Neglected tropical diseases (NTDs), malaria, and tuberculosis have a devastating effect on an estimated 1.6 billion people worldwide. The World Intellectual Property Organization (WIPO) Re:Search consortium accelerates the development of new drugs, vaccines, and diagnostics for these diseases by connecting the assets and resources of pharmaceutical companies, such as compound libraries and expertise, to academic or nonprofit researchers with novel product discovery or development ideas. As the WIPO Re:Search Partnership Hub Administrator, BIO Ventures for Global Health (BVGH) fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations. Since its inception in October 2011, WIPO Re:Search membership has expanded to more than 90 institutions, including leading pharmaceutical companies, universities, nonprofit research institutions, and product development partnerships from around the world. To date, WIPO Re:Search has facilitated over 70 research agreements between Consortium Members, including 11 collaborations focused on anthelmintic drug discovery.
authors.affiliation: BIO Ventures for Global Health, 401 Terry Avenue North, Seattle, WA 98109, United States.
authors.forename: Roopa
authors.initials: R
authors.lastname: Ramamoorthi
authors.affiliation: BIO Ventures for Global Health, 401 Terry Avenue North, Seattle, WA 98109, United States.
authors.forename: Katy M
authors.initials: KM
authors.lastname: Graef
authors.affiliation: BIO Ventures for Global Health, 401 Terry Avenue North, Seattle, WA 98109, United States.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Dent
keywords: Anthelmintic; Capacity-building experience; Cross-sector collaboration; WIPO Re:Search